世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医療機器受託製造市場:機器タイプ(IVD、心臓血管、ドラッグデリバリー(自己注射器、輸液ポンプ)、糖尿病治療、整形外科、眼科、内視鏡、外科)機器クラス(I、II、III)サービス別-2027年までの世界予測


Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Pumps), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgery) Class of Device (I, II, III) Services - Global Forecast to 2027

世界の医療機器受託製造市場は、2022年の712億米ドルから2027年には1189億米ドルに達し、CAGR10.8%で推移すると予測されます。医療機器関連技術の急速な進歩や製造の自動化などが、市場を牽引する要因となってい... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ
2023年1月23日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
400 379 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

世界の医療機器受託製造市場は、2022年の712億米ドルから2027年には1189億米ドルに達し、CAGR10.8%で推移すると予測されます。医療機器関連技術の急速な進歩や製造の自動化などが、市場を牽引する要因となっています。また、医療インフラや啓蒙活動への支出増が、市場プレイヤーに成長機会をもたらすと期待されています。
"2021年の医療機器受託製造市場では、サービス別では、機器開発&製造サービスがより大きなセグメントとなった。"
サービス別では、医療機器受託製造市場は、研究用途と治療用途に区分される。包装・組立サービス分野は、予測期間において医療機器受託製造市場の中で最も急速に成長する分野であると予想されます。多くの医療機器コンポーネントが異なるサプライヤー/ステークホルダーから供給されているため、これらのサービスの必要性が生じます。部品製造のアウトソーシングは増加傾向にあり、このサービスは高い需要が見込まれます。
"IVDデバイスのうち、2021年にはIVD消耗品セグメントのシェアが拡大"
IVDデバイス部門は、さらにIVD消耗品とIVD機器に区分され、そのうち前者が2021年に大きなシェアを占め、予測期間においてより高いCAGRで成長すると予想されます。入手可能な試薬や分析手法の多様化などの要因が、同市場の成長を後押ししています。
"2021年、中国がアジア太平洋地域の医療機器受託製造市場で最大のシェアを占めた"
これは、低コストの労働力、有利な規制環境、急速に進化する医療インフラに起因するものです。CAGRの観点からは、この地域のすべての国の中で中国が最も速い速度で成長し、数年以内に中国の次の製造拠点となることが予想されるインドがそれに続くと予想されます。インドでは、民間および公共投資の増加が、同国の成長に拍車をかけると見られています。


医療機器受託製造市場で参照される主な参加者の内訳は以下の通りです。
- 企業タイプ別(供給側)。Tier1:40%、Tier2:35%、Tier3:25%。
- 役職別Cレベル:30%、Directorレベル:55%、その他。15%
- 地域別北米:20%、欧州:15%、アジア太平洋:25%、中南米:10%、中近東・アフリカ:30
医療機器受託製造市場における主なプレイヤーは、Sanmina Corporation(米国)、TE Connectivity Ltd.(スイス)、Jabil Inc.(スイス)、Jabil Inc.(米国)、ニプロ株式会社(日本)、Integer Holdings Corporation(米国)などが挙げられます。
調査対象範囲
本レポートでは、医療機器受託製造市場を分析し、機器の種類、サービス、機器のクラス、地域などの様々なセグメントに基づいて、同市場の市場規模および今後の成長性を推定することを目的としています。また、同市場の主要企業の競争力分析を、企業プロファイル、製品/サービスの提供、最近の開発、主要な市場戦略とともに掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業が市場の動向を把握し、より大きなシェアを獲得するために役立ちます。本レポートを購入された企業は、以下の5つの戦略のうち1つ、または複数を組み合わせて利用することが可能です。

本レポートでは、以下のポイントについて考察しています。
- 市場浸透。医療機器受託製造市場におけるトッププレイヤーの製品ポートフォリオに関する包括的な情報。本レポートでは、デバイスのクラス、デバイスの種類、サービス、地域に基づいて市場を分析しています。
- 製品開発/イノベーション。医療機器受託製造市場における今後の技術、研究開発活動、製品/サービスの上市に関する詳細な洞察を提供します。
- 市場開発。有利な新興市場に関する包括的な情報。本レポートでは、地域ごとの医療機器受託製造の市場を分析しています。
- 市場の多様化。医療機器受託製造市場における製品/サービス、未開拓地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力の評価。医療機器受託製造市場における主要企業の市場シェア、戦略、製品/サービス、流通網、製造能力に関する詳細な評価。

ページTOPに戻る


目次

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 46
1.2.1 INCLUSIONS AND EXCLUSIONS 46
1.3 MARKET SCOPE 47
1.3.1 MARKETS COVERED 47
FIGURE 1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SEGMENTATION 47
FIGURE 2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL SEGMENTATION 48
1.3.2 YEARS CONSIDERED 48
1.4 CURRENCY CONSIDERED 49
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 49
1.5 STAKEHOLDERS 49
1.6 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH DATA 51
FIGURE 3 RESEARCH DESIGN 51
2.1.1 SECONDARY DATA 52
2.1.1.1 Key data from secondary sources 53
2.1.2 PRIMARY DATA 54
FIGURE 4 PRIMARY SOURCES 54
2.1.2.1 Key data from primary sources 55
2.1.2.2 Key industry insights 55
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 56
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 56
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 57
2.2 MARKET SIZE ESTIMATION 57
FIGURE 8 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 58
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD. 58
FIGURE 10 SUPPLY SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2021) 59
FIGURE 11 DEMAND SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 60
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 61
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 62
2.2.1 TOP-DOWN APPROACH 63
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 64
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY 64
2.4 MARKET SHARE ESTIMATION 64
2.5 STUDY ASSUMPTIONS 65
2.6 RESEARCH LIMITATIONS 65
2.6.1 METHODOLOGY-RELATED LIMITATIONS 65
2.6.2 SCOPE-RELATED LIMITATIONS 65
2.7 RISK ASSESSMENT 66
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 66
2.8 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 66
3 EXECUTIVE SUMMARY 67
FIGURE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2022 VS. 2027 (USD MILLION) 67
FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2022 VS. 2027 (USD MILLION) 68
FIGURE 17 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022 VS. 2027 (USD MILLION) 68
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 69
4 PREMIUM INSIGHTS 70
4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 70
FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET 70
4.2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS 70
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 70
4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 71
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 71
4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX 71
FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2027 71
5 MARKET OVERVIEW 72
5.1 INTRODUCTION 72
5.2 MARKET DYNAMICS 72
FIGURE 23 MARKET DYNAMICS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 72
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS 73
5.2.1 DRIVERS 73
5.2.1.1 Growth in medical devices market in developing countries 73
FIGURE 24 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST) 74
5.2.1.2 Adoption of robotics and automation in manufacturing processes 75
5.2.1.3 Technological advancements in medical device modalities 75
FIGURE 25 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING 76
5.2.1.4 Impact of industry 4.0 on medical device industry 76
TABLE 4 DEFINITIONS OF CRITICAL ELEMENTS IN INDUSTRY 4.0 SYSTEM 76
5.2.2 RESTRAINTS 78
5.2.2.1 Consolidation in medical devices market by acquiring small and medium-sized companies 78
TABLE 5 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY (2019-2022) 78
5.2.3 OPPORTUNITIES 79
5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing countries 79
TABLE 6 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021) 79
FIGURE 26 ASIA PACIFIC: HEALTHCARE EXPENDITURE PER CAPITA (USD) (2002 TO 2019) 80
5.2.3.2 Rising geriatric population and its associated diseases 80
TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050 80
TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST) 81
5.2.4 CHALLENGES 81
5.2.4.1 Lack of constant innovation to balance technological capabilities against costs 81
5.3 PORTER’S FIVE FORCES ANALYSIS 82
FIGURE 27 PORTER’S FIVE FORCES ANALYSIS (2020): MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 82
TABLE 9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.3.1 THREAT OF NEW ENTRANTS 83
5.3.1.1 Growth in overall medical device industry 83
5.3.1.2 Demand for compact, cost-effective, and non-invasive devices 83
5.3.1.3 Consolidation 83
5.3.1.4 Poor financing environment 83
5.3.1.5 Stringent regulatory environment 83
5.3.2 THREAT OF SUBSTITUTES 84
5.3.2.1 Undesirability of existing portfolios 84
5.3.2.2 Combination and integration of multiple technologies 84
5.3.2.3 Availability of alternatives 84
5.3.3 BARGAINING POWER OF SUPPLIERS 84
5.3.3.1 Big medical device contract manufacturing companies 84
5.3.3.2 Institutional technology providers 84
5.3.3.3 Innovative technologies 84
5.3.3.4 Dysfunctional companies 85
5.3.3.5 Academic inventors 85
5.3.4 BARGAINING POWER OF BUYERS 85
5.3.4.1 Few buyers and many sellers 85
5.3.4.2 Buy out threat 85
5.3.4.3 Demand for new pipeline services 85
5.3.4.4 Point of differentiation 85
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.3.5.1 Similar spectrum of services offered 86
5.3.5.2 Similar funding source 86
5.3.5.3 Self-funded big contract manufacturers 86
5.3.5.4 Highly fragmented industry 86
5.4 TARIFF AND REGULATORY LANDSCAPE 86
5.4.1 REGULATORY ANALYSIS 86
5.4.1.1 North America 86
5.4.1.1.1 US 86
TABLE 10 US: CLASSIFICATION OF MEDICAL EQUIPMENT 86
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.4.1.1.2 Canada 87
TABLE 12 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.4.1.2 Europe 88
TABLE 13 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 88
5.4.1.3 Asia Pacific 88
5.4.1.3.1 Japan 88
TABLE 14 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 89
5.4.1.3.2 China 89
TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 89
5.4.1.3.3 India 90
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
5.5 KEY CONFERENCES AND EVENTS IN 2022–2023 93
TABLE 21 DETAILED LIST OF CONFERENCES AND EVENTS 93
5.6 PATENT ANALYSIS 94
5.6.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES 94
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012–NOVEMBER 2022) 94
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICES PATENTS (JANUARY 2012–NOVEMBER 2022) 95
FIGURE 30 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES PATENTS (JANUARY 2012–NOVEMBER 2022) 96
TABLE 22 MEDICAL DEVICES: LIST OF MAJOR PATENTS 96
5.7 TECHNOLOGY ANALYSIS 97
5.7.1 KEY TECHNOLOGIES 97
5.7.1.1 Digital Transformation 97
5.7.1.2 Robotics and Automation 98
5.7.2 ADJACENT TECHNOLOGIES 98
5.7.2.1 Artificial Intelligence 98
5.7.2.2 Big Data 99
5.7.3 COMPLEMENTARY TECHNOLOGIES 99
5.7.3.1 5G 99
5.8 SUPPLY CHAIN ANALYSIS 100
FIGURE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2020) 100
5.9 ECOSYSTEM ANALYSIS 101
FIGURE 32 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS (2020) 101
5.10 TRADE ANALYSIS 101
TABLE 23 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021 101
TABLE 24 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021 102
5.11 YC-YCC ANALYSIS 103
FIGURE 33 YC-YCC SHIFT IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 103
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 104
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 104
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 104
5.12.2 BUYING CRITERIA 104
FIGURE 35 KEY BUYING CRITERIA FOR MEDICAL DEVICES 104
TABLE 26 KEY BUYING CRITERIA FOR MEDICAL DEVICES 105
5.13 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 105
FIGURE 36 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 105
5.14 INDUSTRY TRENDS 106
5.14.1 INCREASING CONSOLIDATION OF ORIGINAL EQUIPMENT MANUFACTURERS AND CONTRACT MANUFACTURING ORGANIZATIONS 106
TABLE 27 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST 5 YEARS 106
TABLE 28 KEY EXAMPLES OF CMO CONSOLIDATION 106
5.14.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING 107
TABLE 29 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS 107
5.14.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES 108
TABLE 30 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS 108
5.14.4 INDUSTRY 5.0 108
5.15 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 109
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE 110
6.1 INTRODUCTION 111
TABLE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 112
6.2 IVD DEVICES 112
TABLE 32 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 33 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 114
6.2.1 IVD CONSUMABLES 114
6.2.1.1 Increasing demand for reagents & kits and focus on COVID-19 screening to drive market 114
TABLE 34 IVD CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115
6.2.2 IVD EQUIPMENT 116
6.2.2.1 Advances in life sciences research to support market 116
TABLE 35 IVD EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
6.3 DIAGNOSTIC IMAGING DEVICES 117
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET 117
TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 118
6.4 CARDIOVASCULAR DEVICES 118
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET 118
TABLE 37 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035 119
TABLE 38 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 120
6.5 DRUG DELIVERY DEVICES 120
TABLE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 122
6.5.1 INFUSION DEVICES AND ADMINISTRATION SETS 122
6.5.1.1 Rising incidence of chronic diseases and number of surgical procedures to fuel market 122
TABLE 41 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
6.5.2 SYRINGES 124
6.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market 124
TABLE 42 SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
6.5.3 INHALERS 126
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market 126
TABLE 43 INHALERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
6.5.4 AUTOINJECTORS AND PEN INJECTORS 127
6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to support market 127
TABLE 44 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY (2019-2022) 128
TABLE 45 AUTOINJECTORS AND PEN INJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
6.6 ORTHOPEDIC DEVICES 129
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET 129
TABLE 46 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 130
6.7 RESPIRATORY CARE DEVICES 131
6.7.1 COVID-19 TO BOOST DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES 131
TABLE 47 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 132
6.8 OPHTHALMOLOGY DEVICES 133
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET 133
TABLE 48 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 134
6.9 SURGICAL DEVICES 134
6.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET 134
TABLE 49 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 135
6.10 DIABETES CARE DEVICES 136
6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET 136
TABLE 50 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS) (2021 VS. 2045) 136
TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 137
6.11 DENTAL DEVICES 137
6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 137
TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 138
6.12 ENDOSCOPY AND LAPAROSCOPY DEVICES 139
6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET 139
TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY AND LAPAROSCOPY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 140
6.13 GYNECOLOGY AND UROLOGY DEVICES 140
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET 140
FIGURE 37 US: NUMBER OF CASES OF SEXUALLY TRANSMITTED DISEASES, 2017 VS. 2021 141
TABLE 54 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR GYNECOLOGY AND UROLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 142
6.14 PERSONAL CARE DEVICES 142
6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET 142
TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 143
6.15 NEUROLOGY DEVICES 144
6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET 144
TABLE 56 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 145
6.16 PATIENT MONITORING DEVICES 145
6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET 145
TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 146
6.17 PATIENT ASSISTIVE DEVICES 146
6.17.1 RISING GERIATRIC POPULATION GLOBALLY TO PROPEL MARKET 146
TABLE 58 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 147
6.18 OTHER DEVICES 148
TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 148
7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE 149
7.1 INTRODUCTION 150
TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 150
7.2 COMPARISON OF DEVICE CLASSIFICATION BY COUNTRY/REGION 150
7.2.1 US 150
7.2.1.1 Class I: General controls 150
7.2.1.2 Class II: General controls with special controls 150
7.2.1.3 Class III: General controls with special controls and premarket approval 151
7.2.2 CANADA 151
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION 151
7.2.3.1 Class I medical devices 152
7.2.3.1.1 Class Is: Non-invasive devices 152
7.2.3.1.2 Class Ir: Reusable surgical instruments 152
7.2.3.1.3 Class Im: Low-risk measuring devices 152
7.2.3.2 Class IIa medical devices 152
7.2.3.3 Class IIb medical devices 152
7.2.3.4 Class III medical devices 152
7.2.4 ASIA PACIFIC 153
7.2.4.1 China 153
7.2.4.2 India 153
7.2.4.3 Japan 154
7.2.4.4 Australia 155
7.3 CLASS II MEDICAL DEVICES 155
7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET 155
TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 156
7.4 CLASS I MEDICAL DEVICES 156
7.4.1 CLASS I MEDICAL DEVICES TO POSSESS MINIMUM POTENTIAL TO HARM USERS 156
TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 157
7.5 CLASS III MEDICAL DEVICES 158
7.5.1 CLASS III MEDICAL DEVICES TO INVOLVE HIGHEST LEVEL OF HEALTH RISKS 158
TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 159
8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE 160
8.1 INTRODUCTION 161
FIGURE 38 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES 161
TABLE 64 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 161
8.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 162
TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 163
8.2.1 DEVICE AND COMPONENT MANUFACTURING SERVICES 163
8.2.1.1 Device manufacturing services to be largest and fastest-growing segment 163
TABLE 67 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
8.2.2 PROCESS DEVELOPMENT SERVICES 165
8.2.2.1 Transition from conventional contract manufacturing to automated contract manufacturing and testing to drive growth 165
FIGURE 39 DEVICE PROCESS DEVELOPMENT SERVICES 165
TABLE 68 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 166
8.2.3 DEVICE ENGINEERING SERVICES 167
8.2.3.1 Complexity of device engineering services to propel segment 167
TABLE 69 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 168
8.3 QUALITY MANAGEMENT SERVICES 168
TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 71 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 169
8.3.1 PACKAGING VALIDATION SERVICES 170
8.3.1.1 Increasing product safety concerns for medical devices to aid market 170
TABLE 72 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
8.3.2 INSPECTION AND TESTING SERVICES 171
8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments 171
TABLE 73 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 171
8.3.3 STERILIZATION SERVICES 172
8.3.3.1 Rising complexity of sterility standards to augment market 172
TABLE 74 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE 172
TABLE 75 STERILIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
8.4 PACKAGING AND ASSEMBLY SERVICES 173
FIGURE 40 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES 174
TABLE 76 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 77 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 175
8.4.1 PRIMARY AND SECONDARY PACKAGING SERVICES 175
8.4.1.1 Growing concerns for patient safety to aid segment 175
TABLE 78 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
8.4.2 LABELING SERVICES 176
8.4.2.1 Export bans and product recalls due to improper labeling to support market 176
TABLE 79 LABELING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 177
8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES 177
TABLE 80 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 178
8.5 OTHER SERVICES 178
TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 179
9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION 180
9.1 INTRODUCTION 181
FIGURE 41 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 181
TABLE 82 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2020–2027 (USD MILLION) 181
9.2 ASIA PACIFIC 182
9.2.1 IMPACT OF RECESSION 182
FIGURE 42 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 183
TABLE 83 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 184
TABLE 84 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 185
TABLE 85 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 86 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 87 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 186
TABLE 88 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 187
TABLE 89 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 90 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 91 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 188
9.2.2 CHINA 188
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market 188
TABLE 92 CHINA: KEY MACROINDICATORS 189
TABLE 93 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 190
TABLE 94 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 95 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 96 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 191
TABLE 97 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 192
TABLE 98 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 99 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 100 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 193
9.2.3 JAPAN 193
9.2.3.1 Universal healthcare reimbursement policies to propel market 193
TABLE 101 JAPAN: KEY MACROINDICATORS 194
TABLE 102 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 195
TABLE 103 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 104 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 105 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 196
TABLE 106 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 197
TABLE 107 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 108 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 109 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 198
9.2.4 MALAYSIA AND SINGAPORE 198
9.2.4.1 Increasing R&D activities and investments by established players to augment market 198
TABLE 110 MALAYSIA: KEY MACROINDICATORS 199
TABLE 111 SINGAPORE: KEY MACROINDICATORS 199
TABLE 112 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 200
TABLE 113 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 114 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 115 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 201
TABLE 116 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 202
TABLE 117 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 118 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 119 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 203
9.2.5 INDIA 203
9.2.5.1 Rising contract manufacturing capabilities to support market 203
TABLE 120 INDIA: KEY MACROINDICATORS 204
TABLE 121 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 205
TABLE 122 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 123 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 124 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 206
TABLE 125 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 207
TABLE 126 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 127 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 128 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 208
9.2.6 AUSTRALIA AND NEW ZEALAND 208
9.2.6.1 Need for advanced medical and diagnostic tools to fuel market 208
TABLE 129 AUSTRALIA: KEY MACROINDICATORS 209
TABLE 130 NEW ZEALAND: KEY MACROINDICATORS 209
TABLE 131 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 210
TABLE 132 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 133 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 134 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 211
TABLE 135 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 212
TABLE 136 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 137 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 138 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
9.2.7 SOUTH KOREA 214
9.2.7.1 High-value imports from other countries to offer opportunities 214
TABLE 139 SOUTH KOREA: MEDICAL DEVICES MARKET (USD BILLION) 214
TABLE 140 SOUTH KOREA: KEY MACROINDICATORS 214
TABLE 141 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 215
TABLE 142 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 143 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 144 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 216
TABLE 145 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 217
TABLE 146 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 147 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 148 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 218
9.2.8 REST OF ASIA PACIFIC 219
TABLE 149 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 219
TABLE 150 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 151 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 152 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 220
TABLE 153 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 221
TABLE 154 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 155 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 156 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 222

 

ページTOPに戻る


 

Summary

The global medical device contract manufacturing market is projected to reach USD 118.9 billion in 2027 from USD 71.2 billion in 2022, at a CAGR of 10.8%. The rapid advancements in technology related to medical devices and automation of manufacturing are factors driving the market. Additionally, increasing expenditure on healthcare infrastructure and awareness campaigns is expected to provide growth opportunities for market players.
“By service, the device development & and manufacturing services was the larger segment in the medical device contract manufacturing market in 2021.”
By service, the medical device contract manufacturing market is segmented into research applications and therapeutic applications. The packaging and assembly services segment is expected to be the fastest-growing segment of the medical device contract manufacturing market in the forecast period. The need for these services arises since many medical device components are supplied by different suppliers/stakeholders. With the outsourcing of component manufacturing on the rise, this service is expected to be in high demand.
“Among IVD devices, the IVD consumables segment accounted for the larger share in 2021.”
By IVD devices segment is further segmented into IVD consumables and IVD equipment, out of which the former held the larger share in 2021, and is expected to grow at a higher CAGR in the forecast period. Factors such as the increase in the variety of available reagents and analytical techniques are pushing the growth of this market.
“In 2021, China accounted for the largest share of the Asia Pacific medical device contract manufacturing market“
This can be attributed to the low-cost labour, favourable regulatory environment, and rapidly evolving healthcare infrastructure. In terms of CAGR, China is expected to grow at the fastest rate out of all countries in the region, followed by India, which is expected to be the next manufacturing hub after China, within a few years. The increasing private and public investments in India are set to fuel the growth of the country.


A breakdown of the primary participants referred to for the medical device contract manufacturing market is provided below:
• By Company Type (Supply-side): Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation: C-level: 30%, Director-level: 55%, and Others: 15%
• By Region: North America: 20%, Europe: 15%, Asia-Pacific: 25%, Latin America: 10%, and Middle East and Africa: 30%
Prominent players in the medical device contract manufacturing market include Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Jabil Inc. (US), Nipro Corporation (Japan), and Integer Holdings Corporation (US).
Research Coverage:
The report analyzes the medical device contract manufacturing market and aims at estimating the market size and future growth potential of this market based on various segments such as device type, service, class of device, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the medical device contract manufacturing market. The report analyzes the market based on the class of device, device type, service, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product/service launches in the medical device contract manufacturing market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for medical device contract manufacturing across regions.
• Market Diversification: Exhaustive information about products/services, untapped regions, recent developments, and investments in the medical device contract manufacturing market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products/services, distribution networks, and manufacturing capabilities of the leading players in the medical device contract manufacturing market.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 46
1.2.1 INCLUSIONS AND EXCLUSIONS 46
1.3 MARKET SCOPE 47
1.3.1 MARKETS COVERED 47
FIGURE 1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SEGMENTATION 47
FIGURE 2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL SEGMENTATION 48
1.3.2 YEARS CONSIDERED 48
1.4 CURRENCY CONSIDERED 49
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 49
1.5 STAKEHOLDERS 49
1.6 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH DATA 51
FIGURE 3 RESEARCH DESIGN 51
2.1.1 SECONDARY DATA 52
2.1.1.1 Key data from secondary sources 53
2.1.2 PRIMARY DATA 54
FIGURE 4 PRIMARY SOURCES 54
2.1.2.1 Key data from primary sources 55
2.1.2.2 Key industry insights 55
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 56
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 56
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 57
2.2 MARKET SIZE ESTIMATION 57
FIGURE 8 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 58
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD. 58
FIGURE 10 SUPPLY SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2021) 59
FIGURE 11 DEMAND SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 60
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 61
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 62
2.2.1 TOP-DOWN APPROACH 63
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 64
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY 64
2.4 MARKET SHARE ESTIMATION 64
2.5 STUDY ASSUMPTIONS 65
2.6 RESEARCH LIMITATIONS 65
2.6.1 METHODOLOGY-RELATED LIMITATIONS 65
2.6.2 SCOPE-RELATED LIMITATIONS 65
2.7 RISK ASSESSMENT 66
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 66
2.8 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 66
3 EXECUTIVE SUMMARY 67
FIGURE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2022 VS. 2027 (USD MILLION) 67
FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2022 VS. 2027 (USD MILLION) 68
FIGURE 17 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022 VS. 2027 (USD MILLION) 68
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 69
4 PREMIUM INSIGHTS 70
4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 70
FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET 70
4.2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS 70
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 70
4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 71
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 71
4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX 71
FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2027 71
5 MARKET OVERVIEW 72
5.1 INTRODUCTION 72
5.2 MARKET DYNAMICS 72
FIGURE 23 MARKET DYNAMICS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 72
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS 73
5.2.1 DRIVERS 73
5.2.1.1 Growth in medical devices market in developing countries 73
FIGURE 24 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST) 74
5.2.1.2 Adoption of robotics and automation in manufacturing processes 75
5.2.1.3 Technological advancements in medical device modalities 75
FIGURE 25 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING 76
5.2.1.4 Impact of industry 4.0 on medical device industry 76
TABLE 4 DEFINITIONS OF CRITICAL ELEMENTS IN INDUSTRY 4.0 SYSTEM 76
5.2.2 RESTRAINTS 78
5.2.2.1 Consolidation in medical devices market by acquiring small and medium-sized companies 78
TABLE 5 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY (2019-2022) 78
5.2.3 OPPORTUNITIES 79
5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing countries 79
TABLE 6 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021) 79
FIGURE 26 ASIA PACIFIC: HEALTHCARE EXPENDITURE PER CAPITA (USD) (2002 TO 2019) 80
5.2.3.2 Rising geriatric population and its associated diseases 80
TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050 80
TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST) 81
5.2.4 CHALLENGES 81
5.2.4.1 Lack of constant innovation to balance technological capabilities against costs 81
5.3 PORTER’S FIVE FORCES ANALYSIS 82
FIGURE 27 PORTER’S FIVE FORCES ANALYSIS (2020): MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 82
TABLE 9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.3.1 THREAT OF NEW ENTRANTS 83
5.3.1.1 Growth in overall medical device industry 83
5.3.1.2 Demand for compact, cost-effective, and non-invasive devices 83
5.3.1.3 Consolidation 83
5.3.1.4 Poor financing environment 83
5.3.1.5 Stringent regulatory environment 83
5.3.2 THREAT OF SUBSTITUTES 84
5.3.2.1 Undesirability of existing portfolios 84
5.3.2.2 Combination and integration of multiple technologies 84
5.3.2.3 Availability of alternatives 84
5.3.3 BARGAINING POWER OF SUPPLIERS 84
5.3.3.1 Big medical device contract manufacturing companies 84
5.3.3.2 Institutional technology providers 84
5.3.3.3 Innovative technologies 84
5.3.3.4 Dysfunctional companies 85
5.3.3.5 Academic inventors 85
5.3.4 BARGAINING POWER OF BUYERS 85
5.3.4.1 Few buyers and many sellers 85
5.3.4.2 Buy out threat 85
5.3.4.3 Demand for new pipeline services 85
5.3.4.4 Point of differentiation 85
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.3.5.1 Similar spectrum of services offered 86
5.3.5.2 Similar funding source 86
5.3.5.3 Self-funded big contract manufacturers 86
5.3.5.4 Highly fragmented industry 86
5.4 TARIFF AND REGULATORY LANDSCAPE 86
5.4.1 REGULATORY ANALYSIS 86
5.4.1.1 North America 86
5.4.1.1.1 US 86
TABLE 10 US: CLASSIFICATION OF MEDICAL EQUIPMENT 86
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.4.1.1.2 Canada 87
TABLE 12 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 87
5.4.1.2 Europe 88
TABLE 13 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 88
5.4.1.3 Asia Pacific 88
5.4.1.3.1 Japan 88
TABLE 14 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 89
5.4.1.3.2 China 89
TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 89
5.4.1.3.3 India 90
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
5.5 KEY CONFERENCES AND EVENTS IN 2022–2023 93
TABLE 21 DETAILED LIST OF CONFERENCES AND EVENTS 93
5.6 PATENT ANALYSIS 94
5.6.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES 94
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012–NOVEMBER 2022) 94
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICES PATENTS (JANUARY 2012–NOVEMBER 2022) 95
FIGURE 30 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES PATENTS (JANUARY 2012–NOVEMBER 2022) 96
TABLE 22 MEDICAL DEVICES: LIST OF MAJOR PATENTS 96
5.7 TECHNOLOGY ANALYSIS 97
5.7.1 KEY TECHNOLOGIES 97
5.7.1.1 Digital Transformation 97
5.7.1.2 Robotics and Automation 98
5.7.2 ADJACENT TECHNOLOGIES 98
5.7.2.1 Artificial Intelligence 98
5.7.2.2 Big Data 99
5.7.3 COMPLEMENTARY TECHNOLOGIES 99
5.7.3.1 5G 99
5.8 SUPPLY CHAIN ANALYSIS 100
FIGURE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2020) 100
5.9 ECOSYSTEM ANALYSIS 101
FIGURE 32 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS (2020) 101
5.10 TRADE ANALYSIS 101
TABLE 23 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021 101
TABLE 24 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021 102
5.11 YC-YCC ANALYSIS 103
FIGURE 33 YC-YCC SHIFT IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 103
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 104
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 104
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 104
5.12.2 BUYING CRITERIA 104
FIGURE 35 KEY BUYING CRITERIA FOR MEDICAL DEVICES 104
TABLE 26 KEY BUYING CRITERIA FOR MEDICAL DEVICES 105
5.13 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 105
FIGURE 36 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 105
5.14 INDUSTRY TRENDS 106
5.14.1 INCREASING CONSOLIDATION OF ORIGINAL EQUIPMENT MANUFACTURERS AND CONTRACT MANUFACTURING ORGANIZATIONS 106
TABLE 27 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST 5 YEARS 106
TABLE 28 KEY EXAMPLES OF CMO CONSOLIDATION 106
5.14.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING 107
TABLE 29 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS 107
5.14.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES 108
TABLE 30 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS 108
5.14.4 INDUSTRY 5.0 108
5.15 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 109
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE 110
6.1 INTRODUCTION 111
TABLE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 112
6.2 IVD DEVICES 112
TABLE 32 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 33 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 114
6.2.1 IVD CONSUMABLES 114
6.2.1.1 Increasing demand for reagents & kits and focus on COVID-19 screening to drive market 114
TABLE 34 IVD CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115
6.2.2 IVD EQUIPMENT 116
6.2.2.1 Advances in life sciences research to support market 116
TABLE 35 IVD EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
6.3 DIAGNOSTIC IMAGING DEVICES 117
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET 117
TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 118
6.4 CARDIOVASCULAR DEVICES 118
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET 118
TABLE 37 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035 119
TABLE 38 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 120
6.5 DRUG DELIVERY DEVICES 120
TABLE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 122
6.5.1 INFUSION DEVICES AND ADMINISTRATION SETS 122
6.5.1.1 Rising incidence of chronic diseases and number of surgical procedures to fuel market 122
TABLE 41 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
6.5.2 SYRINGES 124
6.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market 124
TABLE 42 SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
6.5.3 INHALERS 126
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market 126
TABLE 43 INHALERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
6.5.4 AUTOINJECTORS AND PEN INJECTORS 127
6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to support market 127
TABLE 44 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY (2019-2022) 128
TABLE 45 AUTOINJECTORS AND PEN INJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
6.6 ORTHOPEDIC DEVICES 129
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET 129
TABLE 46 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 130
6.7 RESPIRATORY CARE DEVICES 131
6.7.1 COVID-19 TO BOOST DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES 131
TABLE 47 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 132
6.8 OPHTHALMOLOGY DEVICES 133
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET 133
TABLE 48 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 134
6.9 SURGICAL DEVICES 134
6.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET 134
TABLE 49 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 135
6.10 DIABETES CARE DEVICES 136
6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET 136
TABLE 50 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS) (2021 VS. 2045) 136
TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 137
6.11 DENTAL DEVICES 137
6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 137
TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 138
6.12 ENDOSCOPY AND LAPAROSCOPY DEVICES 139
6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET 139
TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY AND LAPAROSCOPY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 140
6.13 GYNECOLOGY AND UROLOGY DEVICES 140
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET 140
FIGURE 37 US: NUMBER OF CASES OF SEXUALLY TRANSMITTED DISEASES, 2017 VS. 2021 141
TABLE 54 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR GYNECOLOGY AND UROLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 142
6.14 PERSONAL CARE DEVICES 142
6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET 142
TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 143
6.15 NEUROLOGY DEVICES 144
6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET 144
TABLE 56 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 145
6.16 PATIENT MONITORING DEVICES 145
6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET 145
TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 146
6.17 PATIENT ASSISTIVE DEVICES 146
6.17.1 RISING GERIATRIC POPULATION GLOBALLY TO PROPEL MARKET 146
TABLE 58 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 147
6.18 OTHER DEVICES 148
TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 148
7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY CLASS OF DEVICE 149
7.1 INTRODUCTION 150
TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 150
7.2 COMPARISON OF DEVICE CLASSIFICATION BY COUNTRY/REGION 150
7.2.1 US 150
7.2.1.1 Class I: General controls 150
7.2.1.2 Class II: General controls with special controls 150
7.2.1.3 Class III: General controls with special controls and premarket approval 151
7.2.2 CANADA 151
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION 151
7.2.3.1 Class I medical devices 152
7.2.3.1.1 Class Is: Non-invasive devices 152
7.2.3.1.2 Class Ir: Reusable surgical instruments 152
7.2.3.1.3 Class Im: Low-risk measuring devices 152
7.2.3.2 Class IIa medical devices 152
7.2.3.3 Class IIb medical devices 152
7.2.3.4 Class III medical devices 152
7.2.4 ASIA PACIFIC 153
7.2.4.1 China 153
7.2.4.2 India 153
7.2.4.3 Japan 154
7.2.4.4 Australia 155
7.3 CLASS II MEDICAL DEVICES 155
7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET 155
TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 156
7.4 CLASS I MEDICAL DEVICES 156
7.4.1 CLASS I MEDICAL DEVICES TO POSSESS MINIMUM POTENTIAL TO HARM USERS 156
TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 157
7.5 CLASS III MEDICAL DEVICES 158
7.5.1 CLASS III MEDICAL DEVICES TO INVOLVE HIGHEST LEVEL OF HEALTH RISKS 158
TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION) 159
8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE 160
8.1 INTRODUCTION 161
FIGURE 38 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES 161
TABLE 64 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 161
8.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 162
TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 163
8.2.1 DEVICE AND COMPONENT MANUFACTURING SERVICES 163
8.2.1.1 Device manufacturing services to be largest and fastest-growing segment 163
TABLE 67 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
8.2.2 PROCESS DEVELOPMENT SERVICES 165
8.2.2.1 Transition from conventional contract manufacturing to automated contract manufacturing and testing to drive growth 165
FIGURE 39 DEVICE PROCESS DEVELOPMENT SERVICES 165
TABLE 68 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 166
8.2.3 DEVICE ENGINEERING SERVICES 167
8.2.3.1 Complexity of device engineering services to propel segment 167
TABLE 69 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 168
8.3 QUALITY MANAGEMENT SERVICES 168
TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 71 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 169
8.3.1 PACKAGING VALIDATION SERVICES 170
8.3.1.1 Increasing product safety concerns for medical devices to aid market 170
TABLE 72 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
8.3.2 INSPECTION AND TESTING SERVICES 171
8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments 171
TABLE 73 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 171
8.3.3 STERILIZATION SERVICES 172
8.3.3.1 Rising complexity of sterility standards to augment market 172
TABLE 74 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE 172
TABLE 75 STERILIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
8.4 PACKAGING AND ASSEMBLY SERVICES 173
FIGURE 40 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES 174
TABLE 76 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 77 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 175
8.4.1 PRIMARY AND SECONDARY PACKAGING SERVICES 175
8.4.1.1 Growing concerns for patient safety to aid segment 175
TABLE 78 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
8.4.2 LABELING SERVICES 176
8.4.2.1 Export bans and product recalls due to improper labeling to support market 176
TABLE 79 LABELING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 177
8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES 177
TABLE 80 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 178
8.5 OTHER SERVICES 178
TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 179
9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION 180
9.1 INTRODUCTION 181
FIGURE 41 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 181
TABLE 82 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2020–2027 (USD MILLION) 181
9.2 ASIA PACIFIC 182
9.2.1 IMPACT OF RECESSION 182
FIGURE 42 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 183
TABLE 83 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 184
TABLE 84 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 185
TABLE 85 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 86 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 87 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 186
TABLE 88 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 187
TABLE 89 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 90 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 91 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 188
9.2.2 CHINA 188
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market 188
TABLE 92 CHINA: KEY MACROINDICATORS 189
TABLE 93 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 190
TABLE 94 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 95 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 96 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 191
TABLE 97 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 192
TABLE 98 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 99 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 100 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 193
9.2.3 JAPAN 193
9.2.3.1 Universal healthcare reimbursement policies to propel market 193
TABLE 101 JAPAN: KEY MACROINDICATORS 194
TABLE 102 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 195
TABLE 103 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 104 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 105 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 196
TABLE 106 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 197
TABLE 107 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 108 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 109 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 198
9.2.4 MALAYSIA AND SINGAPORE 198
9.2.4.1 Increasing R&D activities and investments by established players to augment market 198
TABLE 110 MALAYSIA: KEY MACROINDICATORS 199
TABLE 111 SINGAPORE: KEY MACROINDICATORS 199
TABLE 112 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 200
TABLE 113 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 114 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 115 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 201
TABLE 116 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 202
TABLE 117 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 118 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 119 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 203
9.2.5 INDIA 203
9.2.5.1 Rising contract manufacturing capabilities to support market 203
TABLE 120 INDIA: KEY MACROINDICATORS 204
TABLE 121 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 205
TABLE 122 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 123 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 124 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 206
TABLE 125 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 207
TABLE 126 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 127 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 128 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 208
9.2.6 AUSTRALIA AND NEW ZEALAND 208
9.2.6.1 Need for advanced medical and diagnostic tools to fuel market 208
TABLE 129 AUSTRALIA: KEY MACROINDICATORS 209
TABLE 130 NEW ZEALAND: KEY MACROINDICATORS 209
TABLE 131 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 210
TABLE 132 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 133 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 134 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 211
TABLE 135 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 212
TABLE 136 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 137 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 138 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
9.2.7 SOUTH KOREA 214
9.2.7.1 High-value imports from other countries to offer opportunities 214
TABLE 139 SOUTH KOREA: MEDICAL DEVICES MARKET (USD BILLION) 214
TABLE 140 SOUTH KOREA: KEY MACROINDICATORS 214
TABLE 141 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 215
TABLE 142 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 143 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 144 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 216
TABLE 145 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 217
TABLE 146 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 147 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 148 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 218
9.2.8 REST OF ASIA PACIFIC 219
TABLE 149 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION) 219
TABLE 150 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 151 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 152 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION) 220
TABLE 153 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION) 221
TABLE 154 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 155 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 156 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION) 222

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る